March 25 (Reuters) - Britain's medicines regulator said on Wednesday it will introduce a framework by the end of 2026, which would allow drugmakers to ask a review of the data for drugs being ...
Health authorities in the U.S. are continuing their move away from animal testing in drug development, with the FDA signaling ...
In April 2025, the FDA announced plans to shift biomedical research for monoclonal antibodies and other medications away from ...
Add Yahoo as a preferred source to see more of our stories on Google. FDA Commissioner Martin Makary on Thursday announced a move away from animal-based drug testing in favor of human-based methods ...
Discover the MHRA's commitment to phasing out animal testing in the UK and adopting innovative alternatives for drug safety ...
Animal testing in Connecticut rakes in millions in federal dollars each year at colleges and universities but, the National Institutes of Health recently announced it is pivoting from using just ...
MedPage Today on MSN
FDA Proposes More Flexibility in Alternatives to Animal Testing in Drug Development
Non-animal testing methods could save drugmakers time and money, officials say ...
Carlin is a vice president at Pathway Policy Group and a veterinarian. Paragas is the CEO and founder of DVLP Medicines and a virologist. The Food and Drug Administration’s recent decision to phase ...
Add Yahoo as a preferred source to see more of our stories on Google. Martin Makary, President Donald Trump's nominee to lead the Food and Drug Administration testifies during his confirmation hearing ...
The U.S. Food and Drug Administration announced Thursday that it will be phasing out a requirement that monoclonal antibodies and other drugs be tested on animals, saying in a news release that there ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results